Loading
Latest filing published 27 Aug 2026 for Forte Biosciences, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Steven Kornfeld appears in our data through filings on Forte Biosciences, Inc. shares, published by SEC (Form 4). The record holds 2 filings, for trades running from 31 July 2023 to 27 August 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 27 August 2026: a transaction, in Forte Biosciences, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations